CG-LAB-12 Testing for Oral and Esophageal Cancer

This policy addresses oral and esophageal brush biopsy techniques (e.g., OralCDx and WATS 3D) used to detect precancerous or cancerous lesions. Anthem considers these tests not medically necessary and not covered for diagnosis, screening, or surveillance in any scenario. No covered indications or exceptions are specified; the determination applies across devices and clinical uses.

"Oral or esophageal brush biopsies for the diagnosis, screening, or surveillance of precancerous or cancerous lesions are considerednot medically necessary."

Sign up to see full coverage criteria, indications, and limitations.